{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_alefacept",
          "type": "Drug",
          "label": "Alefacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fumaric_acid_esters",
          "type": "Drug",
          "label": "Fumaric acid esters",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tazarotene",
          "type": "Drug",
          "label": "Tazarotene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "OffTargetAcitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "RiskPathwayAcitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "AdversePhenotypeAcitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "OffTargetAdalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "RiskPathwayAdalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeAdalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_alefacept",
          "type": "Target",
          "label": "OffTargetAlefacept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_alefacept",
          "type": "Pathway",
          "label": "RiskPathwayAlefacept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_alefacept",
          "type": "Phenotype",
          "label": "AdversePhenotypeAlefacept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_apremilast",
          "type": "Target",
          "label": "OffTargetApremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_apremilast",
          "type": "Pathway",
          "label": "RiskPathwayApremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_apremilast",
          "type": "Phenotype",
          "label": "AdversePhenotypeApremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_brodalumab",
          "type": "Target",
          "label": "OffTargetBrodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_brodalumab",
          "type": "Pathway",
          "label": "RiskPathwayBrodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_brodalumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeBrodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_etanercept",
          "type": "Target",
          "label": "OffTargetEtanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_etanercept",
          "type": "Pathway",
          "label": "RiskPathwayEtanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_etanercept",
          "type": "Phenotype",
          "label": "AdversePhenotypeEtanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_fumaric_acid_esters",
          "type": "Target",
          "label": "OffTargetFumaricAcidEsters",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_fumaric_acid_esters",
          "type": "Pathway",
          "label": "RiskPathwayFumaricAcidEsters",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_fumaric_acid_esters",
          "type": "Phenotype",
          "label": "AdversePhenotypeFumaricAcidEsters",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "OffTargetInfliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "RiskPathwayInfliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "AdversePhenotypeInfliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "OffTargetMethotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "RiskPathwayMethotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "AdversePhenotypeMethotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_secukinumab",
          "type": "Target",
          "label": "OffTargetSecukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_secukinumab",
          "type": "Pathway",
          "label": "RiskPathwaySecukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_secukinumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeSecukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tazarotene",
          "type": "Target",
          "label": "OffTargetTazarotene",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_tazarotene",
          "type": "Pathway",
          "label": "RiskPathwayTazarotene",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_tazarotene",
          "type": "Phenotype",
          "label": "AdversePhenotypeTazarotene",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ustekinumab",
          "type": "Target",
          "label": "OffTargetUstekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ustekinumab",
          "type": "Pathway",
          "label": "RiskPathwayUstekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ustekinumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeUstekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Acitretin为治疗相关类型干扰因子，先前用于掌跖脓疱病"
        },
        {
          "source": "drug_adalimumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Adalimumab在临床上用于多种皮肤病，显示疗效"
        },
        {
          "source": "drug_alefacept",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Alefacept能够调节免疫反应，适用于皮肤病"
        },
        {
          "source": "drug_apremilast",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Apremilast调节炎症并有相关临床效果"
        },
        {
          "source": "drug_brodalumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Brodalumab通过IL-17抑制机制相关"
        },
        {
          "source": "drug_etanercept",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Etanercept用于多种自身免疫性疾病，显示有效性"
        },
        {
          "source": "drug_fumaric_acid_esters",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Fumaric acid esters已用于相关表型治疗"
        },
        {
          "source": "drug_infliximab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Infliximab在系统性免疫治疗中应用"
        },
        {
          "source": "drug_methotrexate",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Methotrexate已用于严重皮肤疾病"
        },
        {
          "source": "drug_secukinumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Secukinumab有针对性IL-17机制的效果"
        },
        {
          "source": "drug_tazarotene",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Tazarotene为类视黄醇药物用于皮肤状态"
        },
        {
          "source": "drug_ustekinumab",
          "target": "disease_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Ustekinumab有效针对免疫相关表型"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_alefacept",
          "target": "n_ot_alefacept",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_alefacept",
          "target": "n_rp_alefacept",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_alefacept",
          "target": "n_adv_alefacept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_alefacept",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_apremilast",
          "target": "n_ot_apremilast",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_apremilast",
          "target": "n_rp_apremilast",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_apremilast",
          "target": "n_adv_apremilast",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_apremilast",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_ot_brodalumab",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_brodalumab",
          "target": "n_rp_brodalumab",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_brodalumab",
          "target": "n_adv_brodalumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_brodalumab",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_etanercept",
          "target": "n_ot_etanercept",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_etanercept",
          "target": "n_rp_etanercept",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_etanercept",
          "target": "n_adv_etanercept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_etanercept",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_fumaric_acid_esters",
          "target": "n_ot_fumaric_acid_esters",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_fumaric_acid_esters",
          "target": "n_rp_fumaric_acid_esters",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_fumaric_acid_esters",
          "target": "n_adv_fumaric_acid_esters",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_fumaric_acid_esters",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_ot_secukinumab",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_secukinumab",
          "target": "n_rp_secukinumab",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_secukinumab",
          "target": "n_adv_secukinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_secukinumab",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_ot_tazarotene",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_tazarotene",
          "target": "n_rp_tazarotene",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_tazarotene",
          "target": "n_adv_tazarotene",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_tazarotene",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_ot_ustekinumab",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在旁靶作用风险"
        },
        {
          "source": "n_ot_ustekinumab",
          "target": "n_rp_ustekinumab",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_ustekinumab",
          "target": "n_adv_ustekinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型的可能性"
        },
        {
          "source": "n_adv_ustekinumab",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消疗效"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.41,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_acitretin"
                ],
                "con": [
                  "H1"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Acitretin用于掌跖脓疱病，具支持证据"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.4,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_adalimumab"
                ],
                "con": [
                  "H2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Adalimumab在多种皮肤病中显示疗效"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.39,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_alefacept"
                ],
                "con": [
                  "H3"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Alefacept能调节免疫反应"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_apremilast"
                ],
                "con": [
                  "H4"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Apremilast调节炎症，有相关临床效果"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.37,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_brodalumab"
                ],
                "con": [
                  "H5"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Brodalumab通过IL-17抑制机制相关"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.36,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_etanercept"
                ],
                "con": [
                  "H6"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Etanercept用于多种自身免疫性疾病，显示有效性"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.35,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_fumaric_acid_esters"
                ],
                "con": [
                  "H7"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Fumaric acid esters已用于相关表型治疗"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.34,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_infliximab"
                ],
                "con": [
                  "H8"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Infliximab在系统性免疫治疗中应用"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.33,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.45,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_methotrexate"
                ],
                "con": [
                  "H9"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Methotrexate已用于严重皮肤疾病"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.32,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_secukinumab"
                ],
                "con": [
                  "H10"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Secukinumab有针对性IL-17机制的效果"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.31,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.35,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_tazarotene"
                ],
                "con": [
                  "H11"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Tazarotene为类视黄醇药物用于皮肤状态"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.3,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.3,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "risk of adverse phenotype",
                "pro": [
                  "n_adv_ustekinumab"
                ],
                "con": [
                  "H12"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Ustekinumab有效针对免疫相关表型"
            ],
            "safety_risk": [
              "潜在不良反应可能抵消疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Acitretin潜在不良反应",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_acitretin",
            "via": [
              "n_ot_acitretin"
            ],
            "to": "n_adv_acitretin",
            "success_criteria": "形成不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "Acitretin与不良表型的潜在关联",
          "风险评估与疗效之间的权衡"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Adalimumab潜在不良反应",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_adalimumab",
            "via": [
              "n_ot_adalimumab"
            ],
            "to": "n_adv_adalimumab",
            "success_criteria": "形成不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "Adalimumab的临床应用与风险评估",
          "不良反应对总体疗效的影响"
        ]
      }
    ],
    "pruned_hypotheses": [
      "H3",
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "seed_request": {
      "should_regenerate": true,
      "reason": "Top 2 候选均无足够机制连通性，且面临较高的冲突风险，需引入多样化候选。",
      "n": 4
    }
  }
}